Amisulpride as a potential disease-modifying drug in the treatment of tauopathies.
Jahreis K, Brüge A, Borsdorf S, Müller FE, Sun W, Jia S, Kang DM, Boesen N, Shin S, Lim S, Koroleva A, Satała G, Bojarski AJ, Rakuša E, Fink A, Doblhammer-Reiter G, Kim YK, Dityatev A, Ponimaskin E, Labus J.
Jahreis K, et al. Among authors: jia s.
Alzheimers Dement. 2023 Dec;19(12):5482-5497. doi: 10.1002/alz.13090. Epub 2023 May 23.
Alzheimers Dement. 2023.
PMID: 37218673